US Biotech Subsidiaries in Germany
This article was originally published in Start Up
Executive Summary
It is tempting during these dark days of the US biotech industry to contemplate establishing a presence in Europe, particularly Germany. The principal lure is funding. A typical German funding package for a US biotech could include a matching grant of $3 million by a German federal agency, alongside a $3 million investment by a German VC fund, as well as another $3 million in state and regional money.